Literature DB >> 30803180

[Autologous peripheral blood stem cell transplantation for POEMS syndrome].

L S Liao1, Z H Zheng, S Qu, T N Wei, Y Xie, Y Lin, B Y Chen, W M Chen.   

Abstract

Six patients with POEMS syndrome who received autologous peripheral blood stem cell transplantation (auto-PBSCT) were retrospectively analyzed. Conditioning regimen was high dose melphalan. Peripheral blood stem cells were collected after mobilization with cyclophosphamide (CTX) and growth factors. One patient presenting hydrothorax and ascites was treated with 3 cycles of lenalidomide and dexamethasone before mobilization. Auto-PBSCT was fairly tolerable. Hematopoietic reconstitution was successful in all patients without transplantation-related mortality. A decrease or normalization of serum vascular epithelial growth factor (VEGF) was observed in all patients at 3 months after transplantation. The neurological remission was seen in 5/6 patients.

Entities:  

Keywords:  Lenalidomide; Melphalan; POEMS syndrome; Peripheral blood stem cell transplantation

Mesh:

Substances:

Year:  2019        PMID: 30803180     DOI: 10.3760/cma.j.issn.0578-1426.2019.03.011

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  1 in total

1.  Gastrointestinal Bleeding Secondary to High-Dose Melphalan Pretreatment in Patients with Multiple Myeloma Was Associated with the Mode of Melphalan Administration.

Authors:  Qunfang Ge; Yi Wang; Huiling Zhu; Kaihong Xu; Lixia Sheng; Xiaoyan Yan; Guifang Ouyang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-11       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.